Keerti V Shah
Overview
Explore the profile of Keerti V Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
4610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gravitt P, Belinson J, Salmeron J, Shah K
Int J Cancer
. 2011 Mar;
129(3):517-27.
PMID: 21384341
Even in the era of highly effective human papillomavirus (HPV) prophylactic vaccines, substantial reduction in worldwide cervical cancer mortality will only be realized if effective early detection and treatment of...
12.
Flores Y, Bishai D, Lorincz A, Shah K, Lazcano-Ponce E, Hernandez M, et al.
Cancer Causes Control
. 2010 Dec;
22(2):261-72.
PMID: 21170578
Objective: To determine the incremental costs and effects of different HPV testing strategies, when compared to Papanicolau cytology (Pap), for cervical cancer screening in Mexico. Methods: A cost-effectiveness analysis (CEA)...
13.
Piyathilake C, Badiga S, Paul P, Vijayaraghavan K, Vedantham H, Sudula M, et al.
Int J Womens Health
. 2010 Nov;
2:7-12.
PMID: 21072292
Background: Studies conducted in the USA have demonstrated that micronutrients such as folate and vitamin B12 play a significant role in modifying the natural history of high-risk human papillomaviruses (HR-HPVs),...
14.
Gravitt P, Paul P, Katki H, Vendantham H, Ramakrishna G, Sudula M, et al.
PLoS One
. 2010 Nov;
5(10):e13711.
PMID: 21060889
Background: While many studies have compared the efficacy of Pap cytology, visual inspection with acetic acid (VIA) and human papillomavirus (HPV) DNA assays for the detection cervical intraepithelial neoplasia and...
15.
Vedantham H, Silver M, Kalpana B, Rekha C, Karuna B, Vidyadhari K, et al.
Cancer Epidemiol Biomarkers Prev
. 2010 May;
19(5):1373-80.
PMID: 20447927
Objectives: Visual inspection of the cervix after acetic acid application (VIA) is widely recommended as the method of choice in cervical cancer screening programs in resource-limited settings because of its...
16.
17.
Bhatla N, Dar L, Patro A, Kumar P, Kriplani A, Gulati A, et al.
Cancer Epidemiol
. 2009 Nov;
33(6):446-50.
PMID: 19931499
Background: To determine human papillomavirus (HPV) types by polymerase chain reaction (PCR)-reverse line blot assay and examine the concordance between HPV by Hybrid Capture 2 (HC2) and PCR on self-collected...
18.
Grabowski M, Viscidi R, Margolick J, Jacobson L, Shah K
J Med Virol
. 2009 May;
81(7):1140-50.
PMID: 19475619
Progressive multifocal leukoencephalopathy (PML) is a severe neurological disorder due to JC virus (JCV) infection. Pre-diagnostic biological markers and risk factors for PML are not well understood. We conducted a...
19.
Sowjanya A, Paul P, Vedantham H, Ramakrishna G, Vidyadhari D, Vijayaraghavan K, et al.
Cancer Epidemiol Biomarkers Prev
. 2009 May;
18(5):1373-8.
PMID: 19423518
Objectives: Our aim was to determine if (1) Hybrid Capture 2 and a PCR-based method were comparable for detection of high-risk human papillomavirus (HPV) clinician-collected and self-collected samples were equally...
20.
Paramsothy P, Jamieson D, Heilig C, Schuman P, Klein R, Shah K, et al.
Obstet Gynecol
. 2008 Dec;
113(1):26-31.
PMID: 19104356
Objective: To examine the association of highly active antiretroviral therapy (HAART) with human papillomavirus (HPV) clearance and progression or regression of cervical cytological abnormalities in women with human immunodeficiency virus...